5 Key Takeaways

• 1

  Researchers developed a self-amplifying RNA (saRNA) therapy for heart recovery after myocardial infarction.

• 2

  The therapy uses a lipid nanoparticle for a single intramuscular injection, enabling sustained hormone production.

• 3

  saRNA delivers instructions for natriuretic peptide type A, promoting cardiovascular regulation.

• 4

  In preclinical models, a single injection improved cardiac function and reduced infarct size for over 4 weeks.

• 5

  The researchers aim to study safety and dosing before advancing to human trials.